Governor Laura Kelly shaped Kansas legislation in 2025 through significant initiatives and responses to diverse issues. She ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst ...

Key Points Merck aims to boost its business by buying Verona Pharma for $10 billion.Through the deal, it will add Ohtuvayre -- a treatment for COPD -- to its portfolio.With the stock valued at ...

In 2021, Merck spent $11.5 billion for Acceleron and its pulmonary arterial hypertension (PAH) treatment, now known commercially as Winrevair. Then in 2023, the New Jersey company ponied up $10.8 ...

Merck plans to pay $107 for each Verona Pharma American Depository Share, which represents eight of the company’s ordinary shares. The deal announced Wednesday has been approved by the boards of ...

The Math Still Doesn’t Add Up Although this acquisition signifies progress, it’s evidently insufficient to resolve Merck’s fundamental issue. The company anticipates a potential $15-20 ...

Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 By Kevin Dunleavy Jul 29, 2025 8:15am Merck layoffs Keytruda Gardasil ...